trial
as of 2026-07-01A Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs)
NCTId NCT00677898
at a glance
— · Completed
Enrollment 239 (actual)
Sponsored by US Department of Veterans Affairs
Primary completion 2012-03
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
239 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2010-03
Primary completion
2012-03
Eligibility
ALL · 18 Years · 70 Years
Interventions & indications
Sponsors
US Department of Veterans AffairsLead Sponsor
Investigators
1
Julie Anne Kreyenbuhl, PhDPrincipal Investigator
Sites
1 total
Baltimore, United States
Facts & assertions
4 sourced
Enrollment
239
Phase
NA
Primary Completion Date
2012-03
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
indication
investigator